Subutinib

subutinib · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subutinib, covering 2013-03-08 to 2013-03-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics [Phase 1]